Please use this identifier to cite or link to this item: http://hdl.handle.net/10668/2053
Título : Left ventricular assist device.
Autor : Jiménez-Navarro, Manuel
Molero, Encarnación
Teresa, Eduardo de
Filiación: [Jiménez-Navarro,M; Molero,E; Teresa,E de] Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain.
Palabras clave : Inhibidores de la enzima convertidora de angiotensina
Insuficiencia cardíaca
Corazón Auxiliar
Antagonistas Adrenérgicos beta
Espironolactona
MeSH: Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protease Inhibitors::Angiotensin-Converting Enzyme Inhibitors
Medical Subject Headings::Diseases::Cardiovascular Diseases::Heart Diseases::Heart Failure
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative::Assisted Circulation::Heart-Assist Devices
Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans
Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Lactones::Spironolactone
Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Neurotransmitter Agents::Adrenergic Agents::Adrenergic Antagonists::Adrenergic beta-Antagonists
Fecha de publicación : 28-Mar-2002
Editorial : Massachusetts Medical Society
Cita Bibliográfica: Jiménez-Navarro M, Molero E, Teresa E de. Left ventricular assist device. N. Engl. J. Med.. 2002; 346(13):1023-5; author reply 1023-5
Abstract: To the Editor: The value of angiotensin-converting– enzyme (ACE) inhibitors, beta-blockers, and spironolactone has been well established by the results of numerous clinical trials. About 70 percent of the patients described by Rose et al. were treated with ACE inhibitors or angiotensin II–receptor antagonists; 35 to 40 percent received spironolactone, and only about 20 percent received beta-blockers. Thus, this population cannot have been considered to be optimally treated from the point of view of medical therapy.
URI: http://hdl.handle.net/10668/2053
Versión del editor : http://www.nejm.org/doi/full/10.1056/NEJM200203283461313
ISSN : 1533-4406 (Online)
0028-4793 (Print)
Appears in Collections:01- Artículos - Hospital Virgen de la Victoria

Files in This Item:
File Description SizeFormat 
Jimenez_Left.pdfCarta publicada80,94 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons